XML 13 R6.htm IDEA: XBRL DOCUMENT v3.25.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities:    
Net loss $ 7,375 $ (34,091)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Provision (recovery) for credit loss 7,038 (367)
Depreciation and amortization 39,015 37,408
Non-cash leases expense 8,894 8,423
Stock-based compensation expense 33,777 34,866
Fair value changes in financial instruments (18,394) 4,851
Write off of deferred financing costs 913  
Deferred income taxes (2,266) 4,931
Other operating activities, net 948 682
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable and contract assets (28,755) (45,898)
Prepaid expenses and other current assets (2,823) (3,197)
Accounts payable and other accrued liabilities 6,094 (2,192)
Accrued payroll and benefits 12,051 (4,936)
Change in operating leases (8,871) (9,233)
Other assets 552 (968)
Net cash provided by (used in) operating activities 55,548 (9,721)
Investing activities:    
Proceeds from corporate owned and property insurance   182
Purchases of property and equipment (10,934) (19,086)
Proceeds from the sale of property and equipment 89 401
Proprietary software development and other software costs (1,759) (2,052)
Purchase price true ups   (3,413)
Minority investments   (210)
Cash paid for acquisitions, net of cash acquired   (113,012)
Net cash used in investing activities (12,604) (137,190)
Financing activities:    
Proceeds from revolving line of credit 386,397 326,468
Repayment of the revolving line of credit (305,518) (278,335)
Repayment of aircraft loan (853) (796)
Proceeds from term loan 200,000 50,000
Repayment of term loan (189,218) (11,094)
Payment of contingent consideration and other purchase price true ups (5,458) (363)
Repayment of finance leases (8,923) (4,384)
Payments of deferred financing costs (2,189) (348)
Proceeds from issuance of common stock for exercised stock options 405 1,973
Proceeds from issuance of common stock in follow-on offering, net of issuance costs   121,776
Proceeds from building sale leaseback 2,500  
Dividend payment to the series A-2 stockholders (4,150) (8,314)
Redemption of series A-2 preferred stock (122,235) (60,000)
Net cash provided by (used in) financing activities (49,242) 136,583
Change in cash, cash equivalents and restricted cash (6,298) (10,328)
Foreign exchange impact on cash balance 99 133
Cash, cash equivalents and restricted cash:    
Beginning of year 12,935 23,240
End of period 6,736 13,045
Supplemental disclosures of cash flows information:    
Cash paid for interest 13,240 10,699
Cash paid for income tax 5,379 2,713
Supplemental disclosures of non-cash investing and financing activities:    
Accrued purchases of property and equipment 777 1,810
Property and equipment purchased under finance leases 8,020 5,806
Common stock issued to acquire new businesses 0 10,712
Acquisitions unpaid contingent consideration 23,419 34,348
Acquisitions contingent consideration paid in common stock $ 6,998 $ 1,087